- Home
- TVTX vs GTX Comparison
TVTX vs GTX Comparison
Compare TVTX & GTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TVTX | GTX |
|---|---|---|
| Founded | N/A | 2018 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3B | 5.8B |
| IPO Year | 2013 | 2021 |
Fundamental Metrics
Financial Performance| Metric | TVTX | GTX |
|---|---|---|
| Price | $62.14 | $29.00 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 5 |
| Target Price | ★ $40.62 | $20.40 |
| AVG Volume (30 Days) | 1.6M | ★ 2.2M |
| Earning Date | 05-04-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 1.56% |
| EPS Growth | ★ 92.89 | 20.63 |
| EPS | N/A | ★ 0.49 |
| Revenue | N/A | ★ $3,584,000,000.00 |
| Revenue This Year | $44.76 | $4.16 |
| Revenue Next Year | $35.51 | $3.27 |
| P/E Ratio | ★ N/A | $58.57 |
| Revenue Growth | N/A | ★ 3.14 |
| 52 Week Low | $17.05 | $12.26 |
| 52 Week High | $66.24 | $36.25 |
Technical Indicators
Market Signals| Indicator | TVTX | GTX |
|---|---|---|
| Relative Strength Index (RSI) | 62.67 | 41.15 |
| Support Level | $53.76 | $28.58 |
| Resistance Level | $66.24 | $32.58 |
| Average True Range (ATR) | 2.59 | 1.16 |
| MACD | 0.27 | -0.15 |
| Stochastic Oscillator | 67.32 | 21.48 |
Price Performance
Historical ComparisonAbout TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease. It is also advancing pegtibatinase, a novel investigational enzyme replacement therapy for the treatment of HCU, a genetic disorder caused by a deficiency in a pivotal enzyme essential to the body.
About GTX Garrett Motion Inc.
Garrett Motion Inc designs, manufactures and sells engineered turbocharger and electric-boosting technologies for light and commercial vehicle original equipment manufacturers (OEMs). The company is a technology leader with expertise in delivering products across gasoline, diesel, natural gas and electrified powertrains. The company also sells its technologies in the aftermarket through its distribution network. The company derives maximum of its revenue from Gas and geographically from Europe.